Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PharmAthene PIP

Healthcare Biotechnology
"PharmAthene Inc is a biodefense company. It is engaged in the development and commercialization of medical countermeasures against biological and chemical weapons in the United States."

Recent & Breaking News (NYSEAM:PIP)

New PharmAthene SparVax® Anthrax Vaccine Data Published In Clinical and Vaccine Immunology

PR Newswire November 11, 2013

PIPEHAWK PLC - Final Results

PR Newswire November 5, 2013

New Non-Clinical Data Confirm SparVax® Anthrax Vaccine Can Provide Protection Against Lethal Anthrax Challenge

PR Newswire September 13, 2013

Wall Street Fundamentals Releases New In-Depth Stock Reports on ACAD, CUR, INO and PIP

Accesswire September 10, 2013

PharmAthene Files Registration Statement On Form S-4 With The Securities and Exchange Commission

PR Newswire September 9, 2013

PharmAthene Presents New SparVax® Data At The Bacillus - ACT 2013 International Anthrax Conference

PR Newswire September 6, 2013

PharmAthene to Present at Rodman & Renshaw Annual Global Investment Conference

PR Newswire September 3, 2013

InvestorsGuru.com 39 Filtered Mid-Day Market Movers Recap

Investors Guru September 1, 2013

PharmAthene to Host Second Quarter 2013 Conference Call and Webcast on Wednesday, August 7, 2013

PR Newswire August 5, 2013

PharmAthene and Theraclone Sciences Announce Merger Agreement to Create Diversified Biologics Company Targeting Government and Commercial Markets

PR Newswire August 1, 2013

PharmAthene To Present At The JMP Securities 2013 Healthcare Conference On Wednesday, July 10, 2013

PR Newswire July 3, 2013

InvestorsGuru.com 21 Filtered Mid-Day Market Movers Recap

Investors Guru June 2, 2013

FDA Lifts Clinical Hold On PharmAthene's SparVax® Anthrax Vaccine Program

PR Newswire May 30, 2013

Delaware Supreme Court Affirms Lower Court's Ruling That SIGA Technologies Breached Its Contractual Obligation To Negotiate In Good Faith

PR Newswire May 26, 2013

PharmAthene Reports First Quarter 2013 Financial And Operational Results

PR Newswire May 8, 2013

PharmAthene To Host First Quarter 2013 Conference Call And Webcast On Wednesday, May 8, 2013

PR Newswire May 6, 2013

New Data Show PharmAthene's Recombinant Bioscavenger Binds To A Broad Spectrum Of Chemical Nerve Agents

PR Newswire April 17, 2013

InvestorsGuru.com Filtered Mid-Day Market Movers Recap

Vivian Danielson March 17, 2013

PharmAthene Reports Year-End 2012 Financial And Operational Results

PR Newswire March 13, 2013

PharmAthene To Host Year-End 2012 Conference Call And Webcast On Wednesday, March 13, 2013

PR Newswire March 12, 2013